We would love to hear your thoughts about our site and services, please take our survey here.
One of the most intelligent and factually correct posts I’ve read on here for a very long time.
There are thousands of passive retail investors who have invested relatively small amounts in Hvivo on the back of a tip either in the mainstream media, the likes of Motley Fool or merely from a friend. As such, the most likely cause of the sell off of the last few days is the fact those retail investors are either not working this week, working from home this week or in the office with more time on their hands. Therefore, they have time to revisit their portfolios before the year end and are noticing holdings which have under preformed; and without bothering to research why or the establish the current health and potential of the company, they simply sell at a small loss. It is unlikely they carried out any meaningful research in the first place.
Thanks Barwick. Says it all really. Happy to be all in with both Hvivo and POLB.
Universal flu vaccine story also covered on BBC Radio 4 Today programs this morning. Hvivo may get the planned challenge study but, as you say Northsea, looking increasingly likely they will leave Seek in their wake. Still time for Seek to pull something out of the bag though!
Universal flu vaccine could counter future pandemic https://www.bbc.co.uk/news/health-63744643
I know this was posted on another thread but this is significant so here again for good measure.
URL link to share mag article please?
…..it also provided a great insight and detailed description of what Hvivo does and the strategy for growth.
I agree Moni.
If anyone reading this hasn’t yet watched the Capital Markets Day presentation, then I strongly suggest you do. It was a very well delivered and reassuring presentation. I thought all company representatives spoke well, particularly Mo and Andrew Catchpole. The new CFO, Stephen Pinkerton, was less eloquent but is clearly still getting to grips with the role - early days. All questions were fielded confidently and answered convincingly.
https://stream.brrmedia.co.uk/broadcast/634fba126815e65bb9fdc500/6357fd8098f6352ab0eba427
Nice timing for Allan Ranking!
Haven’t watched yet.
Link to the recording:
https://stream.brrmedia.co.uk/broadcast/634fba126815e65bb9fdc500/6368b5946f383550d47aea49
There are a few articles confirming Rankin bought 20,702,209 in one transaction - so why did it have no effect on the SP? In fact the SP fell.
Although CF is also chairman of POLB so I will be asking Jeremy to confirm CF’s on going commitment to both POLB and Hvivo. And, while we have an opportunity ask, if CF is still fully committed to the Hvivo spin offs.
Apologies. It is a Poolbeg webinar with Jeremy Skillington on the 8th not Hvivo.
Put questions to Mo at the LSE webinar on Nov. 8
Questions can be emailed to donald.leggat@lse.co.uk
How can 20m+ shares be bought without it effecting the share price?
£1m worth of shares were bought in one transaction within the the last 2-3 months and that didn’t effect the share price either.
Why? How?
Moni - I can’t find recordings of it at the moment.
Hvivo site states “The live broadcast has now finished. Please come back for the archive recording (if made available)”
I don’t see why it wouldn’t be made available.
I’ll email Walbrook.
I submitted a question re. CF’s continued commitment to Hvivo for the Capital Markets Day webcast which was at 09:30 this morning. I was unable to watch but hopefully a recording will be made available. Did anyone watch?
The BoD confirming their proactive efforts to attract II’s and increase exposure in the markets. I’m sure Mo, Stephen Pinkerton and Prof. Openshaw will deliver a compelling presentation.
Feels like the beginning of turning tide.
Thanks Hotchip. Another vote of confidence from experienced investors who understand the markets and recognise the huge potential of both ORPH and POLB.